ArticleThe Journal of biological chemistry2026
Acid ceramidase ASAH1 is a key regulator of epidermal ceramide levels and composition.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Keratinocytes with DNA Aberration Induced by UVB Become Susceptible to Ferroptosis.Antioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maintenance of appropriate ceramide levels and composition in the stratum corneum of the epidermis is essential for skin barrier function. Although ceramide homeostasis is regulated by both synthesis and degradation, the extent of ceramide degradation in the epidermis, as well as the ceramidase responsible for this degradation, has thus far remained unclear. Here, we found that the acid ceramidase ASAH1 is strongly expressed in differentiated human keratinocytes. To investigate its role, we generated ASAH1 KO cells using immortalized human keratinocytes and analyzed their ceramide levels. Under differentiation conditions, ASAH1 KO keratinocytes exhibited a marked accumulation of ceramide classes composed of sphingosine (S) or dihydrosphingosine (dS) and nonhydroxy fatty acid (N) (ceramides NS and NdS). In contrast, ceramides with (an) additional hydroxyl group(s)-such as those containing phytosphingosine (P) or 6-hydroxysphingosine (H) and N or α-hydroxy fatty acid (A) (ceramides NP, NH, AP, and AH)-showed a moderate or no increase. Similar results were obtained upon treatment with SABRAC, a specific ASAH1 inhibitor. In vitro enzyme assays revealed that ASAH1 exhibited strong activity toward NS and NdS, weak activity toward NP and NH, and no activity toward AP. These results indicate that ASAH1-mediated ceramide class-dependent degradation occurs in differentiated human keratinocytes. This degradation likely plays an important role in maintaining appropriate ceramide levels and class composition in the stratum corneum, thereby contributing to the integrity of the skin barrier.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.